Medication info
K-Saisin Tablet 250 mg (Ciprofloxacin Hydrochloride Monohydrate)

K-Saisin Tablet 250 mg (Ciprofloxacin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
SS Pharm Co., Ltd.
Appearance
White, round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199100923 · Notified 1991.01.10 · Insurance code 652601290

Summary

Main use
Treatment of infections of the genitourinary tract, respiratory tract, ear, nose and throat, eyes, and other sites (e.g., intestines, skin, bones and joints)
Who takes it
Adults
Adult dose
○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. Acute infections are usually treated for 5 ~ 10 days; continue treatment for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.

Ingredients

Manufacturer
SS Pharm Co., Ltd.

Efficacy & effects

Treatment of infections of the genitourinary tract, respiratory tract, ear, nose and throat, eyes, and other sites (e.g., intestines, skin, bones and joints)

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat infections caused by various bacteria. It is effective for respiratory infections, excluding acute bronchitis, and community-acquired pneumonia. It also works well for various infections of the ear, nose, and throat, as well as bacterial prostatitis and urinary tract infections. Additionally, it is used for treating bacterial infections in various sites such as the gastrointestinal tract, biliary tract, skin and soft tissues, bones and joints, gynecological infections, and peritonitis. However, fluoroquinolone antibiotics like this should be administered restrictively when no alternative therapy exists due to the potential for serious side effects in some conditions. Overall, this medication is used effectively to improve various bacterial infections.

How to take

Adult dose

○ Usual adult dose: Administer 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. Acute infections are usually treated for 5 ~ 10 days; continue treatment for at least 3 days after symptoms have resolved. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients undergoing hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formula: Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) In severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.

Precautions

This medication may cause serious muscle and tendon issues such as tendonitis and tendon rupture. If these symptoms occur, stop taking the medication immediately. It should not be used in patients with myasthenia gravis as it may worsen symptoms. It is not to be administered to pregnant or breastfeeding women, or children under 18 years old or adolescents in growth. Patients with a history of seizures or hypersensitivity to this medication should also avoid its use. This medication should be used cautiously in patients with severely impaired kidney function, the elderly, and those with seizure disorders. Also, this medication may affect the central nervous system, leading to symptoms such as dizziness, seizures, or mental changes, which should be discussed with a doctor if they occur. This medication has many potential drug interactions, particularly increasing or decreasing the concentration of certain drugs in the blood, so all concomitant medications must be disclosed. Sudden diarrhea or abdominal pain while taking this medication may indicate serious side effects like pseudomembranous colitis and should be reported to healthcare professionals immediately. This medication may cause sensitivity to sunlight, so strong sunlight or UV exposure should be avoided, and if skin rash or itching occurs, discontinuation is advised. Caution is needed when driving or operating machinery, and it is best not to take it with alcohol. Diabetic patients on blood sugar control medications should frequently monitor blood sugar as symptoms of hypoglycemia or hyperglycemia may occur. Store this medication out of reach of children, avoiding direct sunlight or UV exposure.

Side effects

Tendonitis, tendon rupture, peripheral neuropathy, central nervous system effects, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocyte reduction, hemoglobin reduction, decreased hematocrit, granulocytopenia, leukocyte lysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, restlessness, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory loss, loss of taste, tremors, seizures, vertigo, mental confusion, convulsions, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, ataxia, polyneuropathy, visual disturbances, color vision defects, double vision, tinnitus, hearing loss, transient hearing impairment, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular arrhythmia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, membranous colitis, bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechial hemorrhage, erythema multiforme, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint swelling, myasthenia, muscle weakness, partial or complete tendon rupture, renal impairment, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undetermined pain, discomfort, fever, malaise, edema, sweating, gait disturbance, maculopapular rash, purpuric rash, aneurysm, aortic dissection, heart valve regurgitation, heart valve insufficiency, shock, hypotension, chest tightness, increased creatine kinase, elevated serum and urinary myoglobin, rhabdomyolysis, muscle weakness, interstitial pneumonia, cough, abnormal chest X-ray findings, eosinophilia, visual impairment, retinal detachment

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air or moisture exposure, preferably at a cool room temperature, away from direct sunlight.

Appearance and packaging

Appearance

White, round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.